Hypercell Technologies Inc.

BiotechnologyBiotechnologyDiagnosticsAgTech

📍 Ithaca, New York, USA• Founded 2021

StreetZero Signal 75

Be the first to signal interest

About Hypercell Technologies Inc.

Hypercell Technologies is a biotechnology company that develops rapid, on-premise molecular diagnostic tools and antibody-based therapeutics to detect and manage biological contaminants in the food chain. It is based in Ithaca, New York and operates in the Healthcare & Life Sciences sector. The company won the grand prize in the Grow-NY competition on November 15, 2023.

LATEST FUNDINGPrivate Placement

$3.0M

Announced 2026-10-14

TOTAL RAISED$1M

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Hypercell Technologies Inc..

Create free account Sign in

Free plan includes 3 full deal profiles every month.

IN THE NEWS

EMPLOYEES—

FOUNDED2021

HQIthaca, New York, USA

Industry

Biotechnology

Investors

Serra Capital Serra Ventures

Key highlights

Raised $2.96M in private placement in Ithaca, NY.
Won $1M grand prize in Grow-NY competition on Nov 15, 2023.
Develops on-premise molecular diagnostics and antibody therapeutics for food chain contaminants.
Portfolio company of Serra Capital Ag Tech Fund.
Founded in 2021 with focus on food safety and processing efficiency.